Intestinal salt and fluid secretion is stimulated by Escherichia coli heat-stable enterotoxins (ST) through activation of a membrane guanylate cyclase found in the intestine. Guanylin is an endogenous intestinal peptide that has structural similarity to the bacterial peptides. Synthetic preparations of guanylin or hormone that controls intestinal Cl-secretion by a paracrine mechanism via cGMP and that E. coli ST stimulates Cl-secretion by virtue of an opportunistic mechanism through activation of guanylin receptors. (J. Clin. Invest. 1993. 91:2423-2428 
Introduction
In recent years, attention has been focused on the cGMP signal transduction pathway as an important mechanism involved in the control of intestinal Cl -secretion and thus salt and fluid transport. An intestinal membrane guanylate cyclase was recently identified by molecular cloning ( 1, 2) . Expression ofthe specific cDNA encoding an intestinal guanylate cyclase in COS cells resulted in the appearance of a form of guanylate cyclase in membranes that was activated by Escherichia coli heatstable enterotoxin (ST).' The structure of this ST-activated guanylate cyclase was related to the atrial peptide-stimulated guanylate cyclases (1) (2) (3) . E. coli ST is considered to be an important cause ofsecretory diarrhea resulting from the activation of intestinal guanylate cyclase. This bacterial peptide elicits both enhanced Cl-secretion and a reduction in Na+ absorption (4) (5) (6) . E. coli ST-induced secretory diarrhea is associated with substantial morbidity and mortality, especially in the children of developing nations (7, 8) .
The physiological significance of this ST-activated guanylate cyclase in the regulation ofintestinal salt and fluid transport has been reemphasized because of the discovery of guanylin, an endogenous ligand for the intestinal guanylate cyclase (9) . Guanylin was first isolated from rat jejunum with activation of the T84 human intestinal cell guanylate cyclase serving as the bioassay. It is a 15 amino acid peptide containing 4 cysteines and 2 disulfides that are required for biological activity. Guanylin is structurally similar to E. coli ST and competes with '25I-ST for binding sites on intestinal T84 cells. In rat tissues, guanylin bioactivity was observed only in the intestine and kidney (9) . A cDNA that was isolated from a rat intestine cDNA library contained an open reading frame that encodes a 1 5 amino acid precursor ofguanylin ( 10) . Guanylin that was purified from rat intestine represented the carboxy-terminal 15 amino acid portion of preproguanylin. A 600-nucleotide-long mRNA for guanylin was expressed throughout the intestine, but a gradient ofguanylin mRNA was observed with the order of abundance being colon > ileum > jejunum > duodenum. No guanylin mRNA was found in stomach or esophagus. It is likely that guanylin controls cGMP production in tissues other than intestine because kidney proximal tubules, testicular seminiferous tubules, hepatocytes, and airway epithelium of the opossum express the ST-activated guanylate cyclase (1 1-14) .
In this study, we evaluated the effects of synthetic guanylin in comparison with synthetic E. coli ST on Cl-secretion, cGMP production, and inhibition of the binding of 125I-ST to regulator of intestinal fluid and electrolyte transport through a cGMP-guanylate cyclase signal transduction mechanism.
Methods
Cell culture. Tg4 cells (passage 21 obtained from Dr. Jim McRoberts, Torrance, CA) were cultured using DME and Ham's F12 ( 1:1 ) containing 5% FBS, 60 ,gg penicillin, and 100 Mg streptomycin per ml. T94 cells were seeded at 150,000 cells/ ml in plastic cultureware. These cells reached confluence in 3-5 d when cultured on plastic dishes. Subculturing was accomplished using trypsin and Ca/Mg-free PBS by standard methods. Falcon cell culture inserts ofpermeable cyclopore membranes, 25 mm diameter, 0.45 Mm pore size (Fisher Scientific, St. Louis, MO) were first coated with 0.25 ml collagen (Bovine Type I, 1.3 mg/ml; Sigma Chemical Co., St. Louis, MO) for 16 h, while the filters were being sterilized by UV irradiation in a tissue culture hood. Tg4 cells were seeded using 2.5-3.0 X 106 cells per filter in 2-ml medium and cultured using the same medium described above for 7-14 d before using them to measure Cl-secretion in Ussing chamber experiments. The medium was changed 3 times per wk for T84 cells on plastic or permeable supports.
Measurement ofshort circuit current in T84 monolayers. T84 cells raised on permeable filters were mounted in a custom-made Ussing chamber for measurement of Cl-secretion as previously described (22) . The buffer was a Krebs-Ringer-bicarbonate solution, pH 7.4, containing 10 mM glucose for both the apical and basolateral reservoirs (5 ml volume). The Ussing apparatus was water jacketed to maintain the buffer temperature at 370C. Both reservoir buffer solutions were mixed and oxygenated by bubbling 95% 02/5% CO2 through the medium. Short circuit current (Isc) was measured continuously, and potential difference across the epithelium was measured intermittently. These data are the ±SEM of 3 experiments. At the arrows, 1 uM guanylin was added to the basolateral reservoir followed by the addition of 1 uM guanylin to the apical reservoir. Zero time was when the cells were initially mounted in the chamber.
the basolateral reservoir of 100MM bumetanide, an inhibitor of the Na-K-2C1 cotransporter (Fig. 2 A) . Addition of 1 MM acetylcholine to the basolateral reservoir caused only a small increase in Isc after bumetanide treatment. Acetylcholine elicited a marked increase in Isc in control TM cells when added after (Fig. 2 B) .
Synthetic ST 5-17 was used because this peptide has the minimum structure required to activate guanylate cyclase with a potency and efficacy equal to naturally occurring bacterial STs (9, 25) . When 100 MM bumetanide was added before 1 AM guanylin, this peptide caused only a small increase in Isc (Fig.  3) . These data show that guanylin-activated and ST-stimulated Isc in T84 cells are both dependent upon the bumetanide-sensitive Na-K-2C1 cotransporter localized in the basolateral membrane of Tg4 cells (16) . Acetylcholine, which stimulates Clsecretion via a calcium/phosphoinositide signal transduction pathway in T84 cells ( 17, 20) , also had little effect on Isc when bumetanide was present. 100 AM bumetanide did not completely block the Isc response to agonists, especially when bumetanide was added first (Fig. 3) . Perhaps an additional Cltransport pathway exists to accomplish the basolateral membrane transport of Cl-such as Cl-/HCO-and Na+/H' exchangers. The potencies of guanylin or ST were assessed using a cumulative concentration-response protocol for these preparations of rat guanylin and E. coli (Fig. 4) . Stimulation of Isc occurred at 10 nM guanylin, and subsequent addition of 100 or 1,000 nM guanylin elicited proportionally greater increases in Isc. In comparison, E. coli ST 5-17 stimulated Isc at 1 nM, suggesting that this peptide was more potent than guanylin. The concentrations of guanylin or ST used in these experiments did not appear to elicit maximal responses, but these curves seem to be parallel with the potency of guanylin about one-tenth that of ST 5-17. The magnitude of Isc responses to 1 MM guanylin and 100 nM E. coli ST 5-17 were similar in T84 cells that had not been pretreated with lower concentrations of these agonists (data not shown).
The relative potencies ofguanylin and E. coli also assessed by measuring the accumulation of cGMP in T84 cells exposed to these peptides. Using this bioassay, guanylin appeared to be less potent than E. coli (Fig. 5) 
Discussion
Several key observations provided information suggesting that the intestinal membrane guanylate cyclase located in apical membranes of enterocytes may be controlled by an endogenous ligand. Discovery that E. coli ST was a potent activator of intestinal guanylate cyclase and that cGMP could influence intestinal fluid secretion was the first evidence for an endo-ST (5, 6). The observation that ST-stimulated guanylate cyclase was also found in opossum kidney proximal tubules and other epithelia of this species provided additional rationale that this enzyme would be regulated by an endogenous ligand instead of a bacterial peptide (1 1-14) . Molecular cloning of rat and human cDNAs encoding a putative ST receptor protein with structural similarity to the atrial peptide receptor/guanylate cyclases further supported the proposal that an endo-ST existed ( 1, 2) . Purification of the peptide, guanylin, from rat intestine using the T84 human intestinal cell cGMP response as a bioassay has provided a candidate for the endogenous hormone that regulates intestinal C1-secretion (9) . Data presented in this manuscript are consistent with the hypothesis that guanylin serves this function in the intestine because synthetic guanylin activates guanylate cyclase and stimulates Clsecretion in cultured human intestinal T84 cells.
Guanylin [1, 2] ) may be influenced, leading to different types and/or densities ofapical receptors in T84 cells cultured on permeable substrates. It is unlikely that these potency differences are due to using a rat peptide in human intestinal cells, since rat and human guanylin peptides are highly conserved ( 10, (26) (27) (28) . In the carboxylterminal 15 amino acids (i.e., amino acids 101-115 of preproguanylin) only one substitution was observed at position 102 between rat and human peptides. Moreover, the potencies of rat and human guanylin 101-1 15 for increases in cGMP levels of T84 cells were not different (26) . The potency of human guanylin to increase Isc in the rat colon (26) was similar to the potency of rat guanylin on Isc of Tg4 cells in this study. In both instances, threshold increases in Isc were observed at 10 nM guanylin. Another consideration is that the secreted form of guanylin may be a longer peptide than the 15 amino acid peptide that was purified from rat jejunum (9) . An acid-labile bond between Asp 100 and Pro 10 1 would have yielded the 15 amino acid peptide upon boiling in acetic acid. Perhaps proteolytic processing ofproguanylin occurs before secretion using an upstream site such as the arginine at position 93 or 94, which is conserved in rat, human, and mouse guanylin precursor sequences ( 10, (26) (27) (28) . A much longer peptide would be generated by cleavage at the lysine pairs found at amino acids 54, 55 for rat and mouse or positions 37, 38 found in human or mouse preproguanylin ( 10, (26) (27) (28) secretion and thus fluid and salt secretion by the local release of guanylin at sites where this peptide can bind to its receptors on the apical membrane of intestinal crypt cells could be an important physiological mechanism. Activation of guanylin receptors by structurally similar peptides secreted by enteric bacteria reveals an opportunistic mechanism, which helps to explain the powerful pathophysiologic effects of E. coli ST on intestinal salt and fluid secretion.
